Serum dopamine-β-Hydroxylase activity and alcohol withdrawal symptoms

G. Bagdy, M. Arató

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Fifty male alcoholics had serum dopamine-β-hydroxylase (DBH) activity, and serum prolactin (PRL) levels measured on the day of withdrawal, and 22 of them also on days 7 and 28 after it. The obtained values were related to the development of withdrawal symptoms. Treatment was begun with meprobamate on the first day of withdrawal, and from day 7 it was completed with disulfiram (250 and 500 mg/day, respectively). Serum DBH activity decreased significantly by day 7, however a further fall of it occurred by day 28 only in patients receiving high doses (500 mg) of disulfiram. PRL levels rose over the period of withdrawal which reached significance level on day 28. No correlation was found between serum DBH activity and the severity of withdrawal symptoms. Serum DBH activity did not differ from that of the healthy controls at either point of time, while serum PRL level was significantly elevated throughout the period of the study.

Original languageEnglish
Pages (from-to)45-50
Number of pages6
JournalDrug and Alcohol Dependence
Volume19
Issue number1
DOIs
Publication statusPublished - 1987

Fingerprint

Substance Withdrawal Syndrome
Mixed Function Oxygenases
withdrawal
Prolactin
Disulfiram
Dopamine
alcohol
Alcohols
Serum
Meprobamate
alcoholism
Alcoholics
Values

Keywords

  • Alcohol withdrawal
  • Serum dopamine-β-hydroxylase activity
  • Serum prolactin

ASJC Scopus subject areas

  • Medicine(all)
  • Behavioral Neuroscience
  • Toxicology
  • Health(social science)

Cite this

Serum dopamine-β-Hydroxylase activity and alcohol withdrawal symptoms. / Bagdy, G.; Arató, M.

In: Drug and Alcohol Dependence, Vol. 19, No. 1, 1987, p. 45-50.

Research output: Contribution to journalArticle

@article{d4f3116cba7f4281a8fe81fac6ce8596,
title = "Serum dopamine-β-Hydroxylase activity and alcohol withdrawal symptoms",
abstract = "Fifty male alcoholics had serum dopamine-β-hydroxylase (DBH) activity, and serum prolactin (PRL) levels measured on the day of withdrawal, and 22 of them also on days 7 and 28 after it. The obtained values were related to the development of withdrawal symptoms. Treatment was begun with meprobamate on the first day of withdrawal, and from day 7 it was completed with disulfiram (250 and 500 mg/day, respectively). Serum DBH activity decreased significantly by day 7, however a further fall of it occurred by day 28 only in patients receiving high doses (500 mg) of disulfiram. PRL levels rose over the period of withdrawal which reached significance level on day 28. No correlation was found between serum DBH activity and the severity of withdrawal symptoms. Serum DBH activity did not differ from that of the healthy controls at either point of time, while serum PRL level was significantly elevated throughout the period of the study.",
keywords = "Alcohol withdrawal, Serum dopamine-β-hydroxylase activity, Serum prolactin",
author = "G. Bagdy and M. Arat{\'o}",
year = "1987",
doi = "10.1016/0376-8716(87)90086-X",
language = "English",
volume = "19",
pages = "45--50",
journal = "Drug and Alcohol Dependence",
issn = "0376-8716",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Serum dopamine-β-Hydroxylase activity and alcohol withdrawal symptoms

AU - Bagdy, G.

AU - Arató, M.

PY - 1987

Y1 - 1987

N2 - Fifty male alcoholics had serum dopamine-β-hydroxylase (DBH) activity, and serum prolactin (PRL) levels measured on the day of withdrawal, and 22 of them also on days 7 and 28 after it. The obtained values were related to the development of withdrawal symptoms. Treatment was begun with meprobamate on the first day of withdrawal, and from day 7 it was completed with disulfiram (250 and 500 mg/day, respectively). Serum DBH activity decreased significantly by day 7, however a further fall of it occurred by day 28 only in patients receiving high doses (500 mg) of disulfiram. PRL levels rose over the period of withdrawal which reached significance level on day 28. No correlation was found between serum DBH activity and the severity of withdrawal symptoms. Serum DBH activity did not differ from that of the healthy controls at either point of time, while serum PRL level was significantly elevated throughout the period of the study.

AB - Fifty male alcoholics had serum dopamine-β-hydroxylase (DBH) activity, and serum prolactin (PRL) levels measured on the day of withdrawal, and 22 of them also on days 7 and 28 after it. The obtained values were related to the development of withdrawal symptoms. Treatment was begun with meprobamate on the first day of withdrawal, and from day 7 it was completed with disulfiram (250 and 500 mg/day, respectively). Serum DBH activity decreased significantly by day 7, however a further fall of it occurred by day 28 only in patients receiving high doses (500 mg) of disulfiram. PRL levels rose over the period of withdrawal which reached significance level on day 28. No correlation was found between serum DBH activity and the severity of withdrawal symptoms. Serum DBH activity did not differ from that of the healthy controls at either point of time, while serum PRL level was significantly elevated throughout the period of the study.

KW - Alcohol withdrawal

KW - Serum dopamine-β-hydroxylase activity

KW - Serum prolactin

UR - http://www.scopus.com/inward/record.url?scp=0023139264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023139264&partnerID=8YFLogxK

U2 - 10.1016/0376-8716(87)90086-X

DO - 10.1016/0376-8716(87)90086-X

M3 - Article

C2 - 3816539

AN - SCOPUS:0023139264

VL - 19

SP - 45

EP - 50

JO - Drug and Alcohol Dependence

JF - Drug and Alcohol Dependence

SN - 0376-8716

IS - 1

ER -